Literature DB >> 33568954

Prevalence and Associated Factors of Depression among Patients with HIV/AIDS in Lahore, Pakistan: Cross-Sectional Study.

Khunsa Junaid1, Hassan Ali1, Ali Akram Khan2, Taimoor Akram Khan2, Aabish Mehreen Khan2, Amjad Khan3, Rabia Nazim2, Khadija Tahira1.   

Abstract

BACKGROUND: Depression is defined as a psychiatric disorder characterized by depressed mood, lack of concentration, diminished energy, disturbed sleep, and low self-esteem. Depression is more prevalent in HIV/AIDS patients than the general population. There is no published study available that reveals the present status of depression among HIV patients in Pakistan. As such, the present study was conducted to determine the prevalence and associated factors of depression among HIV/AIDS patients attending the HIV clinic of Jinnah Hospital, Lahore, Pakistan.
METHODS: A hospital-based cross-sectional study was carried out from February to March 2019 in Lahore. Data were collected from 158 HIV/AIDS patients using a pretested, standardized, structured interviewer-administered questionnaire. Nonprobability convenience sampling was used to recruit the study participants. Depression was evaluated using the Patient Health Questionnaire. SPSS version 23 was used to analyze the data. Binary logistic regression models were used to determine the various factors associated with depression. AORs with 95% CIs were used to assess the magnitude of associations between depression and associated factors.
RESULTS: The mean age of the study participants was 35.03 years±9.123. Prevalence of depression among HIV/AIDS patients was 32.2%. Living in a rural area (AOR 5.60, 95% CI 2.20, 14.15), fear of stigma and discrimination (AOR 3.505, 95% CI 1.364, 9.008), having worked abroad (AOR 3.017, 95% CI 1.134, 8.031), and history of substance abuse (AOR 4.147, 95% CI 1.673, 10.28) were significantly associated with depression.
CONCLUSION: The prevalence of depression among HIV/AIDS patients is very high in Pakistan. Therefore, it is suggested that guidelines formulated to screen and treat depression among HIV patients.
© 2021 Junaid et al.

Entities:  

Keywords:  HIV/AIDS; PHQ9 scale; convenience sampling; depression

Year:  2021        PMID: 33568954      PMCID: PMC7868298          DOI: 10.2147/PRBM.S268099

Source DB:  PubMed          Journal:  Psychol Res Behav Manag        ISSN: 1179-1578


  12 in total

1.  Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study.

Authors:  Hernando Knobel; Jordi Alonso; José L Casado; Julio Collazos; Juan González; Isabel Ruiz; José M Kindelan; Alexia Carmona; Javier Juega; Antonio Ocampo
Journal:  AIDS       Date:  2002-03-08       Impact factor: 4.177

2.  Prevalence and associated factors of depression among people living with HIV in two cities in China.

Authors:  Xiaoyou Su; Joseph T F Lau; Winnie W S Mak; K C Choi; Lin Chen; Junmin Song; Yan Zhang; Guanglu Zhao; Tiejian Feng; Xi Chen; Chuliang Liu; Jun Liu; De Liu; Jinquan Cheng
Journal:  J Affect Disord       Date:  2013-02-27       Impact factor: 4.839

3.  Anxiety and depression amongst patients enrolled in a public sector antiretroviral treatment programme in South Africa: a cross-sectional study.

Authors:  Michele Pappin; Edwin Wouters; Frederik L R Booysen
Journal:  BMC Public Health       Date:  2012-03-27       Impact factor: 3.295

4.  Prevalence and correlates of depressive symptoms in HIV-positive patients: a cross-sectional study among newly diagnosed patients in Yaoundé, Cameroon.

Authors:  Rodrigue Minya L'akoa; Jean Jacques N Noubiap; Yixin Fang; Félicien Enyime Ntone; Christopher Kuaban
Journal:  BMC Psychiatry       Date:  2013-09-22       Impact factor: 3.630

Review 5.  Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses.

Authors:  Sergio Rueda; Sanjana Mitra; Shiyi Chen; David Gogolishvili; Jason Globerman; Lori Chambers; Mike Wilson; Carmen H Logie; Qiyun Shi; Sara Morassaei; Sean B Rourke
Journal:  BMJ Open       Date:  2016-07-13       Impact factor: 2.692

6.  Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia.

Authors:  Getachew Tesfaw; Getinet Ayano; Tadesse Awoke; Dawit Assefa; Zelalem Birhanu; Getenet Miheretie; Genet Abebe
Journal:  BMC Psychiatry       Date:  2016-11-02       Impact factor: 3.630

7.  Prevalence of depression in people living with HIV and AIDS at the Kalafong Provincial Tertiary Hospital Antiretroviral Clinic.

Authors:  Brett van Coppenhagen; Helene S Duvenage
Journal:  S Afr J Psychiatr       Date:  2019-07-22       Impact factor: 1.550

8.  Benefits and risks of rapid initiation of antiretroviral therapy.

Authors:  Nathan Ford; Chantal Migone; Alexandra Calmy; Bernhard Kerschberger; Steve Kanters; Sabin Nsanzimana; Edward J Mills; Graeme Meintjes; Marco Vitoria; Meg Doherty; Zara Shubber
Journal:  AIDS       Date:  2018-01-02       Impact factor: 4.177

9.  Criterion-related validity and reliability of the Urdu version of the patient health questionnaire in a sample of community-based pregnant women in Pakistan.

Authors:  John A Gallis; Joanna Maselko; Karen O'Donnell; Ke Song; Kiran Saqib; Elizabeth L Turner; Siham Sikander
Journal:  PeerJ       Date:  2018-07-17       Impact factor: 2.984

10.  Prevalence and associated factors of depression among patients with HIV/AIDS in Hawassa, Ethiopia, cross-sectional study.

Authors:  Bereket Duko; Epherem Geja; Mahlet Zewude; Semere Mekonen
Journal:  Ann Gen Psychiatry       Date:  2018-10-30       Impact factor: 3.455

View more
  1 in total

Review 1.  A Systematic Review and Meta-Analysis on Depression and Associated Factors among Adult HIV/AIDS-Positive Patients Attending ART Clinics of Ethiopia: 2021.

Authors:  Bitew Tefera Zewudie; Shegaw Geze; Yibeltal Mesfin; Muche Argaw; Haimanot Abebe; Zebene Mekonnen; Shegaw Tesfa; Bogale Chekole; Betelhem Tadesse; Agere Aynalem; Tadele Lankrew
Journal:  Depress Res Treat       Date:  2021-10-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.